Clin2
NCT07422831Possibly a fitEnrolling by invitation

Intermittent glucose sensor use for type 2 diabetes

Type 2 DiabetesNon Insulin Dependent Diabetes

Part of Hormones & metabolism clinical trials.

This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
188 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have type 2 diabetes
  • You have not used a continuous glucose monitor (CGM) in the past year
  • You are not using insulin currently or in the past year
  • You have a smartphone that can run the Stelo app

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05633628Recruiting
Wear a continuous glucose monitor with type 2 diabetes

This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.

Stockholm
NCT07308925Not yet recruiting
Real-time vs intermittent glucose monitoring in type 2 diabetes

This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.

Bogotá
NCT06837103Recruiting
Continuous glucose monitor and coaching for type 2 diabetes

This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.

Toronto, Ontario
NCT05766488Enrolling by invitation
Testing continuous glucose monitor use in type 2 diabetes care

This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.

Omaha, Nebraska
NCT06658067Recruiting
Study on continuous glucose monitors for type 2 diabetes

This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.

New Haven, Connecticut
NCT06805786Recruiting
Switching from scanned to real-time CGM for type 2 diabetes

This study tests whether switching from a FreeStyle Libre 2 (which you scan to check sugar) to a Dexcom G7 (which sends sugar readings automatically to your phone) can improve blood sugar control in adults with type 2 diabetes who use insulin.

Toronto, Ontario

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.